This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Lyell Immunopharma, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Rachel Christina Lynn: Innovator in Immunopharma
Introduction
Rachel Christina Lynn is an accomplished inventor based in South San Francisco, CA. She has made significant contributions to the field of immunopharma, particularly through her innovative research and development efforts. With a focus on cellular biology, Rachel has been instrumental in advancing our understanding of immune responses.
Latest Patents
Rachel holds a patent titled "NR4A-Deficient Cells Expressing C-Jun and Uses Thereof." This patent highlights her work in manipulating cellular mechanisms to enhance therapeutic applications. The patent showcases her expertise and commitment to developing novel solutions in the field.
Career Highlights
Rachel is currently employed at Lyell Immunopharma, Inc., where she continues to push the boundaries of immunotherapy. Her role at the company allows her to collaborate with leading scientists and contribute to groundbreaking research. Rachel's dedication to her work has positioned her as a key player in the industry.
Collaborations
Rachel collaborates with various professionals in her field, including her coworker Viola Lam. Their partnership exemplifies the importance of teamwork in driving innovation and achieving research goals.
Conclusion
Rachel Christina Lynn is a notable inventor whose work in immunopharma is paving the way for future advancements. Her patent and contributions to Lyell Immunopharma, Inc. reflect her commitment to improving health outcomes through innovative research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile